Opto Circuits (India) Ltd. (OCI), one of the leading Indian companies that develop, manufacture and market medical devices for global markets, today announced its financial results for the second quarter ended September 30th, 2009.

Consolidated net sales grew by 18 % to Rs 255.73 crore, as compared to Rs 217.02 crore in the corresponding period of last year. Consolidated net profit grew by 18% to Rs 66.93 crore, as compared to Rs 56.73 crore in the corresponding period of last year.

Also Read   Related Stories News Now - BHEL bags Rs 5,040 cr Contract for installing 4x600 MW Thermal Sets - Axiom Education is now Mexus Education - Unity Infraprojects bags the prestigious order to re-develop R N Cooper Hospital - SAIL Q2 PAT of Rs 1,663 cr betters Q1 by 25%, lower by 17% YoY - Scomi Inks Joint Bidding Agreement with Geodesic Techniques - CFM International to set up Maintenance Training Center in GMR's Aviation SEZ

Also Read   Related Stories News Now - Markets end lower ahead of May F&O expiry - Parsvnath posts Rs 23 cr loss in Q4 - Educomp net down 57% at Rs 61 cr in Jan-Mar qtr - DLF Q4 net plunges 39% to Rs 211 cr - Provogue Q4 net profit down 71% at Rs 1.81 cr More

Half Year Performance:

Consolidated net sales for the half year ended September 30, 2009, grew by 23% to Rs. 486.09 crore, as compared to Rs. 394.38 crore in H1FY09. Net profit for half year ended September 30, 2009 was at Rs. 126.13 crore, as compared to Rs. 101.72 crore in H1FY09, registering a growth of 24%.

Earnings per Share for H1FY10 stood at Rs. 6.90 (Basic) and Rs. 6.88 (Diluted).

Management Comments:

Vinod Ramnani, Chairman and Managing Director, OCI, commented, “The strategic and long term agreements signed through our wholly-owned US subsidiary, Criticare Systems Inc., have helped us diversify our product portfolio and expand our presence in many key markets in Europe, United States and Latin America.”

Quarter Highlights:

During the quarter, the company has successfully raised Rs. 400 crore through the QIP route. OCI has allotted 2,14,30,484 equity shares to institutional investors at Rs. 186.65 (Rs. 10/- face value and Rs. 176.65 Premium).

The quarter saw OCI’s wholly-owned US-based subsidiary, Criticare Systems Inc. (CSI), sign a long-term agreement with a European manufacturer and distributor of medical equipment. The agreement involves the supply of private label patient monitoring systems by CSI to the partner as well as cooperation in sales and distribution of anaesthetic gas delivery products in several key markets, both in the United States and Europe.

CSI also signed a strategic multi-year OEM contract with another US company to private label its anaesthesia monitor for the signed partner. The agreement leverages CSI’s unique anesthesia gas monitoring technology in applications that involve the calibration and maintenance of anesthesia equipment in some of the leading hospitals in the United States.

OCI developed a new pocket sized finger pulse Oximeter (SPO2 monitor), M50 NanoSAT™. M50 NanoSAT™ is one of the smallest and lightest of such monitors and has received CE Approval for marketing and distribution in key markets like Europe, Asia and Latin America.

OCI signed long-term development agreement with a leading OEM customer. The agreement provides for a joint development program focused on a new modular and MRI-compatible patient monitoring system. The system will be based on Criticare’s new eVision™ platform.

About Opto Circuits (India) Ltd.
Opto Circuits (India) Ltd. (OCI) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is a 100 percent EOU and a leading manufacturer of healthcare equipment in India. The product profile includes digital thermometers, sensors, pulse oximeters, patient monitoring systems, stents, catheters and other innovative products. In 2001, OCI acquired 60 per cent stake in Advanced Micronic Devices (AMDL) to market and distribute its products in India. Mediaid came into existence with the acquisition of the patient monitoring division of Palco Labs, US, in end-2003 and it now directly markets OCI’s products in the US. OCI acquired EuroCor GmbH in 2006. EuroCor manufactures Cardiac Stents of various types, including Drug Eluting Coronary stents. In April 2007, OCI ventured into new product segments - Urology, Gastroenterology, Gynaecology and Orthopaedics after acquiring Devon Innovations Private Limited (Bangalore) and Ormed Medical Technology Limited (Chennai). OCI completed the acquisition of US based Criticare Systems, Inc. in April 2008. Criticare designs, manufactures, and markets leading edge patient monitoring systems, vital signs monitors and gas benches for a wide range of hospitals and alternate health care environments throughout the world.
Visit us at www.optoindia.com

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end lower ahead of May F&O expiry - Parsvnath posts Rs 23 cr loss in Q4 - Educomp net down 57% at Rs 61 cr in Jan-Mar qtr - DLF Q4 net plunges 39% to Rs 211 cr - Provogue Q4 net profit down 71% at Rs 1.81 cr

Read Business news in  Advertisements -  India's no. 1 Property Site. Click here to know more -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  Journey on, We are by Your Side. Click here to know more -  "Discover The Power of One" -  Help a Child Achieve her. Click to know more -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  Learn How One City is Running on FOOD SCRAPS. -  1 billion in saving for Unilever without any tangles. -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More -  2 Lac Apartments, 1 Lac House / Plots. Click here